Table 1 Baseline patient characteristics
Patient characteristics | Study cohort, n = 124 |
|---|---|
Age, years, mean ± SD | 65.3 ± 9.7 |
Sex, n (%) | |
 Male | 110 (89%) |
 Female | 14 (11%) |
Aetiology, n (%) | |
 ARLD | 51 (41%) |
 Viral | 46 (37%) |
 Other/Unknown | 15 (12%) |
 MASLD | 12 (10%) |
Cirrhosis, n (%) | 110 (89%) |
Varices, n (%)a | 50/80 (63%) |
 Low-risk varicesb | 18/50 (36%) |
 High-risk varices | 32/50 (64%) |
Non-selective beta blocker treatment, n (%) | 42 (34%) |
Endoscopic treatment of varices, n (%) | 14 (11%) |
CTP score, points, median (IQR) | 5 (5–6) |
 A, n (%) | 108 (87%) |
 B7, n (%) | 16 (13%) |
ALBI score, mean ± SD | −2.5 ± 0.4 |
 Stage 1, n (%) | 48 (39%) |
 Stage 2, n (%) | 76 (61%) |
Prior surgery/local therapy, n (%) | 21 (17%) |
Extrahepatic spread, n (%) | 36 (29%) |
ECOG PS, n (%) | |
 0 | 72 (58%) |
 1 | 52 (42%) |
Baseline imaging modality, n (%) | |
 Computed tomography | 96 (77%) |
 Magnetic resonance imaging | 28 (23%) |